Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Made in China: TaiMed wins FDA OK for a 'breakthrough' HIV therapy for drug-resistant patients
8 years ago
Pharma
Jakobovits abruptly exits Adicet; Stanford researchers uncover mechanistic details of ALS using CRISPR
8 years ago
News Briefing
Faster, more convenient Opdivo dosing schedules gives Bristol-Myers added edge in battle of the PD-1 blockbusters ...
8 years ago
Pharma
ViewPoint Therapeutics gets $35M to advance non-surgical alternative for cataracts, presbyopia
8 years ago
Financing
After bagging Shire’s cell therapy castoff, Caladrius stock climbs
8 years ago
Pharma
Searching for HIV cure, Gilead's new 'shock and kill' combo swats back lethal virus in monkeys
8 years ago
Discovery
Quiet and confidential IPO registration? Who needs it. Autolus shouts about its next big raise
8 years ago
Financing
Cambridge star Magenta teams up with Heidelberg on bone marrow R&D pact that includes $334M in potential milestones
8 years ago
R&D
Pharma
Judgment day is coming: Federal judge orders Martin Shkreli to forfeit a small fortune following felony convictions
8 years ago
People
Global CRO Parexel woos outsourcing veteran Jamie Macdonald to the helm
8 years ago
People
Outsourcing
Arcus to raise $99M IPO; Vanda wants marketing approval for jet lag
8 years ago
News Briefing
Stock flies high on Clearside’s PhIII macular edema trial results as drug improves vision
8 years ago
R&D
Pharma
Chinese medicine player Tasly considers Hong Kong IPO for its biotech arm: report
8 years ago
Financing
China
Watch out below: Dermira axes acne drug after a catastrophic PhIII failure
8 years ago
R&D
Santhera’s Raxone fails NIH’s MS study in latest setback, shares plunge
8 years ago
R&D
Gene editing expert Homology details the numbers in its back-ended $1B Novartis deal, files for $100M IPO
8 years ago
Financing
Is tech money bad for business? Silicon Valley cash makes some biopharma VCs bristle, others cheer
8 years ago
Financing
Startups
Celgene hands over $101M in cash to launch a research collaboration with protein player Vividion
8 years ago
R&D
Pharma
Unum plays its first glimpse of human data in an $86M IPO, revealing two deaths and an FDA hold
8 years ago
Financing
Startups
EpimAb nabs Bin Peng from NIBR; Jeffrey Chodakewitz exits Vertex; Christiana Stamoulis is president at Unum
8 years ago
Peer Review
Activist investor Alex Denner in the spotlight again as the Medicines Company shrinks its board
8 years ago
People
Perlara collaborates with Harvard/Undiagnosed Diseases Network; Verona shares soar on positive CF data
8 years ago
News Briefing
Amid a boisterous fundraising week, BioMedPartners airs $107M biotech fund
8 years ago
Financing
Asian investor commits $15M to launch new protein degradation biotech startup Cullgen out of UNC
8 years ago
Startups
First page
Previous page
1061
1062
1063
1064
1065
1066
1067
Next page
Last page